It is better to light one candle, 

than to curse the dark

Jeroen (Jerome) is a Dutch computational biologist with a current focus on developing new cancer immunotherapies through the discovery of antigens. The basis for such discoveries lies in RNA/DNA sequencing data collected from tissues kindly donated by cancer patients. He is currently active for CureVac NL in Amsterdam, with a special focus new classes of antigens, immunopeptidomics, sequencing technology and computational pipelines.

He conducted his PhD research on prostate cancer oncogenomics and epigenetics in 2017-2023 at the Netherlands Cancer Insitute. Prior, Jeroen has conducted research on nascent CRISPR technology in 2016 at the Broad Institute of MIT and Harvard and on bacterial genomics (Argonaute protein) at the Department of Microbiology at Wageningen UR. Jeroen has received a BSc and MSc in Molecular Life Sciences from his alma mater, Wageningen UR.